Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Medical Officer

SVP, Chief Scientific Officer

Chief Financial Officer

President, Chief Exec Officer

SVP, General Counsel

Interim CFO

SVP, Principal Accntng Officer

Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase II clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine, an oral vaccine platform, which is in preclinical stage; coronavirus vaccine, which is in Phase II clinical trial for the treatment of SARS-CoV-2 infection; human papillomavirus therapeutic vaccine that targets HPV 16 and HPV 18 for cervical cancers and precancerous cervical dysplasia. The company has license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.

Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-28	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2024-03-28	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Chief Scientific Officer
2024-03-18	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-03-18	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-03-18	Premium	acquired	Premium	Premium	Premium	President, Chief Exec Officer
2024-03-18	Premium	acquired	Premium	Premium	Premium	SVP, Chief Scientific Officer
2024-03-18	Premium	acquired	Premium	Premium	Premium	SVP, General Counsel
2024-02-02	Premium	sold (taxes)	Premium	Premium	Premium	SVP, General Counsel
2024-02-02	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2024-02-02	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Chief Scientific Officer
2023-12-15	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2023-12-08	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Chief Scientific Officer
2023-12-08	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2023-12-08	Premium	sold (taxes)	Premium	Premium	Premium	SVP, General Counsel
2023-12-08	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2023-06-26	Premium	acquired	Premium	Premium	Premium	-
2023-06-26	Premium	acquired	Premium	Premium	Premium	-
2023-06-26	Premium	acquired	Premium	Premium	Premium	-
2023-06-26	Premium	acquired	Premium	Premium	Premium	-
2023-06-26	Premium	acquired	Premium	Premium	Premium	-
2023-06-12	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-03-28	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Chief Scientific Officer
2023-03-17	Premium	acquired	Premium	Premium	Premium	President, Chief Exec Officer
2023-03-17	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-03-17	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer

VXRT - Vaxart Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for VXRT